Biopsy Devices Market to Grow with a CAGR of 6.18% through 2030
Rising adoption of minimally invasive techniques are expected
to drive the Global Biopsy Devices Market growth in the forecast period,
2026-2030.
According to TechSci Research report, “Biopsy
Devices Market – Global Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2030F”, the Global Biopsy Devices Market stood at USD
6.17 billion in 2024 and is anticipated to grow with a CAGR of 6.18% in the
forecast period through 2030. Biopsy devices have emerged as indispensable tools
in the field of medicine, particularly in the diagnosis and treatment of
cancer. These devices play a critical role in obtaining tissue samples for
pathological examination, enabling early disease detection, accurate diagnosis,
and personalized treatment plans.
ne
of the primary drivers fueling the biopsy devices market is the global surge in
cancer cases. Cancer is a leading cause of mortality worldwide, and early
detection is pivotal in improving survival rates. Biopsy devices are essential
for collecting tissue samples from suspicious lesions or tumors, which are then
examined to confirm the presence of cancer and determine its type and stage. As
cancer incidence continues to rise, the demand for biopsy devices is expected
to grow in tandem.
The world's demographic landscape is shifting, with a
significant increase in the elderly population. Older individuals are more
prone to various diseases, including cancer. This demographic change is
directly contributing to the growth of the biopsy devices market, as older
individuals often require more frequent diagnostic procedures, including
biopsies. The aging population is expected to be a major driver of market
growth for years to come.
The continuous evolution of medical technology is
revolutionizing the field of biopsy devices. Innovations such as image-guided
biopsies, liquid biopsies, and advanced imaging techniques have significantly
improved the accuracy and precision of tissue sampling. These technological
advancements not only enhance the diagnostic capabilities of biopsy devices but
also reduce patient discomfort and the risk of complications. Healthcare
providers and patients alike are benefiting from these advances, driving market
growth.
Traditional surgical biopsies can be invasive and
associated with potential risks and complications. However, the development of
minimally invasive biopsy techniques is transforming patient care. Procedures
like fine-needle aspiration and vacuum-assisted biopsy offer less invasive
alternatives, reducing recovery times and patient discomfort. These techniques
are gaining popularity and are contributing to the expanding market for biopsy
devices.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Biopsy Devices Market.”
The Global Biopsy Devices Market is segmented into Product Type, Disease Type, Anatomy, Guidance Technique, Regional
Distribution, and Company.
Based on Product Type, the liquid biopsy segment is experiencing the fastest growth within the biopsy devices market. This surge is primarily driven by the increasing demand for non-invasive, accurate, and rapid diagnostic tools in oncology. Liquid biopsies, which analyze circulating tumor DNA (ctDNA) and other biomarkers from blood samples, offer significant advantages over traditional tissue biopsies, including reduced patient discomfort, quicker turnaround times, and the ability to monitor disease progression and treatment response in real-time.
Based on Region, The Asia Pacific region is anticipated to witness the highest growth rate in the liquid biopsy market, attributed to increasing healthcare expenditures, rising cancer prevalence, and growing awareness of advanced diagnostic technologies. As healthcare systems worldwide continue to prioritize early detection and personalized medicine, the adoption of liquid biopsy technologies is expected to accelerate, solidifying its position as the fastest-growing product type in the biopsy devices market.
Major companies operating in Global Biopsy
Devices Market are:
- Argon Medical Devices, Inc.
- B. Braun SE
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Cook Medical Inc.
- Conmed Corporation
- FUJIFILM Holdings Corporation
- GE HealthCare
- Inrad, Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Global Biopsy Devices Market is poised for
significant growth in the coming years. The continuous evolution of biopsy
techniques, including minimally invasive procedures and advanced imaging
guidance, will make these diagnostic methods more patient-friendly, accurate,
and accessible. Moreover, the integration of robotics and artificial intelligence
into biopsy procedures is likely to enhance precision and efficiency. The
adoption of liquid biopsies, which offer non-invasive alternatives for disease
monitoring, is expected to gain momentum. With a growing global population,
particularly aging demographics, the demand for biopsy devices to diagnose a
wide range of medical conditions is set to increase.” said Mr. Karan Chechi,
Research Director of TechSci Research, a research-based management consulting
firm.
“Biopsy Devices Market - Global Industry Size,
Share, Trends, Opportunity, and Forecast, Segmented By Product Type
(Tissue Biopsy, Liquid Biopsy), By Disease Type (Cancer, Infections, Autoimmune
Disorders, Non-Cancerous Indications, Others), By Anatomy (Breast, Lung, Bone,
Liver, Uterus/Cervix/Ovary, Abdomen, Prostate, Cardiac, Skin, Others), By
Guidance Technique (X-Ray-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided
Biopsy, CT-Guided Biopsy), By Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Biopsy Devices Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Biopsy Devices Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States-
10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com